Cannabix Technologies Inc. (CSE: BLO)
BLO trades on the Canadian Securities Exchange in Life Sciences, headquartered in British Columbia. Numbers below come from the TMX issuer list, Yahoo Finance closes and the Bank of Canada rate, each with its source.
Issuer list, sector and C$ market cap: TMX Group TSX and TSXV listed companies, as of November 13, 2026. US$ figures convert C$ at 1.4257 C$ per US$, the Bank of Canada daily rate for November 13, 2026. Close and returns: Yahoo Finance daily closes for BLO.CN, last bar 2026-11-13, computed by MarginsX.
Profile
| Field | Value |
|---|---|
| Ticker | BLO on the Canadian Securities Exchange |
| Yahoo symbol | BLO.CN |
| Sector | Life Sciences, Medical Devices |
| Headquarters | British Columbia |
| Listed | The TMX list gives no listing date |
| Listing type | TMX leaves listing type blank for long-listed issuers |
| Shares outstanding | Not on the TMX list |
| Also listed on | No interlisting on the TMX list |
| Index membership | Not in an S&P/TSX index per the TMX list |
| SEC CIK | 0002025793 |
| Website | No company website on record |
Returns
| Window | Return |
|---|---|
| 1 day | -8.9% |
| 1 week | -11.1% |
| 1 month | +20.0% |
| 3 months | -30.8% |
| 6 months | -49.3% |
| Year to date | -37.9% |
| 1 year | -35.7% |
| From 52-week high | -59.1% |
| 52-week range | C$0.3000 to C$0.8800 |
Links
SEDAR+ is linked for searching only; nothing on this page is taken from it.
Recent Canadian filings by type
29 documents in 4 types. Each title links to the document at its source.
MD&A (1)
| Document | Type | Filed |
|---|---|---|
| Management Discussion and Analysis for YE 2025 378.2 kB | MD&A | No date |
News release (20)
| Document | Type | Filed |
|---|---|---|
| Cannabix Technologies to Present Multi-Drug Breath Technology at BC Centre for Excellence on Substance Use Disorders | News release | 2026-11-13 |
| Cannabix Technologies Announces Detection of Fentanyl in Human Breath | News release | 2026-11-09 |
| Cannabix Technologies Evaluating Expansion into Breath-Based Health and Biomarker Market with Proprietary BCU “VOC” Platform | News release | 2026-10-28 |
| Cannabix Technologies Delivers First Breath-Based DOT-Like Multi-Drug Testing Panel for Recent-Use Detection | News release | 2026-10-20 |
Management information circular / proxy (6)
| Document | Type | Filed |
|---|---|---|
| Notice of meeting and Information circular 430.7 kB | Management information circular | No date |
| Notice of meeting 214.9 kB | Notice of meeting | No date |
| Notice and Access Notification 74.6 kB | Notice of meeting | No date |
| Form of proxy 91.6 kB | Form of proxy / voting instruction | No date |
Other (2)
| Document | Type | Filed |
|---|---|---|
| Financial Statements for YE 2025 492.9 kB | Financial statements (period not stated) | No date |
| Confirmation of CDS Notice 213.7 kB | Other | No date |
Sources: Company investor-relations website (links only, documents not copied). Documents filed only on SEDAR+ are not copied here; search SEDAR+ for the full record.
Trading halts
No CIRO halt notices for this company in our data.
Source: Canadian Investment Regulatory Organization (CIRO), Halts/Resumptions newsroom, notices since 2024-10-15.
Upcoming events
No upcoming earnings date, call or meeting announced in the SEC filings and newswire releases we read.
Source: dates read from the company's SEC filings and newswire releases; each row links to the announcement.
US private placements (SEC Form D)
| Filed | Securities | Sold | Offered | Filing |
|---|---|---|---|---|
| 2024-06-04 | Equity, Debt, Option To Acquire | US$440K | US$440K | SEC EDGAR |
Source: SEC EDGAR Form D filings matched on SEC CIK. Amounts are US$ as filed.
Peers in Life Sciences
| Ticker | Company | Exchange | Market cap (C$) | 1 month | 1 year |
|---|---|---|---|---|---|
| NAV | NAVCO Pharmaceuticals Inc. | TSXV | C$285K | 0.0% | 0.0% |
| EVMT | Evome Medical Technologies Inc. | TSXV | C$301K | 0.0% | 0.0% |
| ARC | ARCpoint Inc. | TSXV | C$332K | 0.0% | 0.0% |
| VXL | Vaxil Bio Ltd. | TSXV | C$398K | -24.1% | -35.3% |
| WAVE | Waverley Pharma Inc. | TSXV | C$540K | +100.0% | 0.0% |
The app has the price chart, every filing, private raises and the full peer set for BLO.
Open in the app